Country delegations to the UN Commission on Narcotic Drugs (CND) don’t usually vote on things… The protocol is that member states reach consensus on language and policy (often meaning that the final language reflects the lowest common denominator). Usually this diplomatic process works and delegates compromise. However, at the most recent inter-sessional meeting of the CND on 5th November, some delegates drew “red lines” and staked out non-negotiable positions on key issues.
Women of China - On Friday October 23, the Brookings-Tsinghua Center for Public Policy "Reform or Perseverance" panel discussion took place in Beijing, for experts to discuss findings from a recent evaluation into the effectiveness and costs of international drugs policy, ahead of next year's UN meeting on the "World Drug Problem" (UNGASS 2016).
Myanmar Times - Repressive drug laws and corruption have contributed to Myanmar’s spiralling narcotics problem, according to advocacy groups, who are calling on the new government to launch a change of policy.
The United Nations Development Programme (UNDP), the UN agency charged with developing strategies to reduce global poverty, has strongly criticised current international drug policy, highlighting the disastrous costs it is producing – particularly for the world’s poor. In the agency’s formal submission to the UN General Assembly Special Session (UNGASS) on drugs (PDF), launched at the annual UN Commission on Narcotic Drugs which began last week in Vienna, the UNDP argues:
Volkskrant - De Verenigde Naties houden voor het eerst in twintig jaar een conferentie over drugs, op verzoek van drie Latijns-Amerikaanse landen die vinden dat het tijd wordt een alternatief te zoeken voor de War on Drugs.
The Lancet - On April 19–21, 2016, the UN General Assembly Special Session on Drugs (UNGASS) will convene to chart a course for the future to tackle the world's drugs problem. The 2016 UNGASS represents a rare opportunity to reassess the global approach to drugs and to move towards drug policies that more effectively address the three UN pillars of peace and security, human development, and human rights. We believe that we need a new consensus that includes a commitment to revise the range of indicators used to assess and improve drug policy effectiveness.